最新の情報は下記 URL でご確認いただけます (外部サイトへ移動します) 。
https://ftp.ncbi.nlm.nih.gov/pub/clinvar/tab_delimited/archive/
表のタイトル行が青色の項目は、クリックすることでソートすることができます。
| Type | Name | Gene Symbol | Clinical Significance | Chromosome | Start | Stop | Reference Allele | Alternate Allele | Review Status | Other IDs |
|---|---|---|---|---|---|---|---|---|---|---|
| (GRCh37) | ||||||||||
| single nucleotide variant | NM_024675.4(PALB2):c.49-1G>A | PALB2 | Likely pathogenic | 16 | 23649451 | 23649451 | C | T | criteria provided, multiple submitters, no conflicts | - |
| Deletion | NM_024675.4(PALB2):c.3008del (p.Asn1003fs) | PALB2 | Pathogenic | 16 | 23632788 | 23632788 | GT | G | criteria provided, single submitter | - |
| Indel | NM_024675.4(PALB2):c.2116_2129delinsG (p.Thr706fs) | PALB2 | Likely pathogenic | 16 | 23641346 | 23641359 | GTATTTAAAGGAGT | C | criteria provided, single submitter | - |
| Duplication | NM_024675.4(PALB2):c.1848dup (p.Glu617Ter) | PALB2 | Pathogenic | 16 | 23641626 | 23641627 | C | CA | criteria provided, single submitter | - |
| Duplication | NM_024675.4(PALB2):c.1539dup (p.Gly514fs) | PALB2 | Pathogenic | 16 | 23646327 | 23646328 | C | CT | criteria provided, single submitter | - |
| Deletion | NM_024675.4(PALB2):c.715del (p.Arg239fs) | PALB2 | Pathogenic | 16 | 23647152 | 23647152 | CT | C | criteria provided, multiple submitters, no conflicts | - |
| single nucleotide variant | NM_024675.4(PALB2):c.50T>G (p.Leu17Ter) | PALB2 | Pathogenic | 16 | 23649449 | 23649449 | A | C | criteria provided, single submitter | - |
| Duplication | NM_024675.4(PALB2):c.3164dup (p.Tyr1055Ter) | PALB2 | Likely pathogenic | 16 | 23625361 | 23625362 | G | GT | criteria provided, single submitter | - |
| single nucleotide variant | NM_024675.4(PALB2):c.2192T>G (p.Leu731Ter) | PALB2 | Pathogenic/Likely pathogenic | 16 | 23641283 | 23641283 | A | C | criteria provided, multiple submitters, no conflicts | - |
| single nucleotide variant | NM_024675.4(PALB2):c.1919C>G (p.Ser640Ter) | PALB2 | Pathogenic | 16 | 23641556 | 23641556 | G | C | criteria provided, multiple submitters, no conflicts | - |